Papillomaviruses: prophylactic vaccine prospects (Q44182045)

30 November 2017

1 reference

title

Papillomaviruses: prophylactic vaccine prospects (English)

1 reference

30 November 2017

1 reference

D R Lowy

1

1 reference

30 November 2017

J T Schiller

series ordinal

2

1 reference

30 November 2017

publication date

1 January 1999

1 reference

Biochimica et Biophysica Acta

30 November 2017

published in

1 reference

30 November 2017

volume

1423

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

M1-8

1 reference

Genital human papillomavirus infection

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Human papillomaviruses and associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

The role of HPV in the etiology of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

The epidemiology of cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Mechanism of HPV E6 proteins in cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Interactions of the human papillomavirus E7 protein with cell cycle regulators

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Oncogenes and antioncogenes in the development of HPV associated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Sexually transmitted infection as a cause of anal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Immunology of the human papilloma virus in relation to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

A quantitative in vitro focus assay for bovine papilloma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Chimeric Papillomavirus-like Particles

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2898%2900037-7

7 January 2021

10.1016/S0304-419X(98)00037-7

Identifiers

DOI

1 reference

30 November 2017

1 reference